| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/21/1994 | CA1330274C Cereal product |
| 06/18/1994 | CA2111603A1 Stable antibody solution and stabilization of antibody |
| 06/16/1994 | DE4322570C1 Stromal cell lines from human bone marrow cells - contain SV-40 DNA with defective origin of replication, useful as feeder cells, for prodn. of growth factors and for gene expression |
| 06/16/1994 | CA2111321A1 Process for the production of polypeptides |
| 06/15/1994 | EP0601360A1 Progenitor B cell stimulating factor |
| 06/15/1994 | EP0601043A1 Hybrid cytokines |
| 06/15/1994 | EP0600993A1 Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 06/15/1994 | EP0600880A1 INTERLEUKIN 1$g(b) PROTEASE AND INTERLEUKIN 1$g(b) PROTEASE INHIBITORS |
| 06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
| 06/15/1994 | EP0469045B1 SYNTHETIC $i(PSEUDOMONAS) $i(AERUGINOSA) PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS |
| 06/15/1994 | EP0469017B1 Expression of human apolipoproteins ai-milano in yeast |
| 06/15/1994 | CA2110827A1 Antiviral antibiotic bu-4724v and preparation thereof |
| 06/14/1994 | US5321124 Art (rev) protein of human T-cell leukemia virus |
| 06/14/1994 | US5321123 Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods |
| 06/14/1994 | US5321010 Proteins for inhibiting adhesion of platelets to collagen |
| 06/14/1994 | US5320956 Ovarian, esophageal and cervical carcinomas |
| 06/14/1994 | US5320952 Cells transformed with dna sequences; genetic engineering |
| 06/14/1994 | US5320947 Immune reactivity to expressed activated oncogenes for diagnosis of malignancy |
| 06/14/1994 | US5320941 DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom |
| 06/12/1994 | CA2110934A1 Human cns receptors of the nmda-r1 family |
| 06/09/1994 | WO1994012668A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
| 06/09/1994 | WO1994012661A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 06/09/1994 | WO1994012659A1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
| 06/09/1994 | WO1994012658A1 Process for producing foreign protein |
| 06/09/1994 | WO1994012648A2 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 06/09/1994 | WO1994012644A2 Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom |
| 06/09/1994 | WO1994012641A1 Haemophilus outer membrane protein |
| 06/09/1994 | WO1994012639A2 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | WO1994012638A2 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | WO1994012636A1 Method of controlling polypeptide production in bacteria |
| 06/09/1994 | WO1994012635A2 Novel seven transmembrane receptors |
| 06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | WO1994012630A2 Method for producing polypeptide via bacterial fermentation |
| 06/09/1994 | WO1994012626A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
| 06/09/1994 | WO1994012618A1 PURIFICATION, COMPOSITION AND SPECIFICITY OF HEPARINASE I, II, AND III FROM $i(FLAVOBACTERIUM HEPARINUM) |
| 06/09/1994 | WO1994012539A1 Multifunctional neurotrophic factors |
| 06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |
| 06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 06/09/1994 | WO1994012528A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | WO1994012526A1 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3 |
| 06/09/1994 | WO1994012524A1 Protein hydrolysate derived from mucosal tissue |
| 06/09/1994 | WO1994012521A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | WO1994012513A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | WO1994012216A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/09/1994 | WO1994012215A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | WO1994012214A1 Humanized antibodies reactive with cd18 |
| 06/09/1994 | WO1994012213A1 Method of producing antibodies with conjugates of b-cell-antigen and denatured carrier |
| 06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/09/1994 | WO1994005793A3 Dna sequences involved in soraphen biosynthesis by myxobacteria |
| 06/09/1994 | CA2150477A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/09/1994 | CA2150117A1 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | CA2150116A1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | CA2150027A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | CA2150025A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | CA2149889A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | CA2149862A1 Multifunctional neurotrophic factors |
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2149025A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | CA2148935A1 Purification of fusion proteins comprising gm-csf and il-3 |
| 06/09/1994 | CA2145384A1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
| 06/09/1994 | CA2128705A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 06/08/1994 | EP0600396A2 Intestinal protozoal vaccines |
| 06/08/1994 | EP0600372A1 Process for the preparation of proinsulin with correctly linked cystin bridges |
| 06/08/1994 | EP0600278A2 Glutamate receptor protein and gene coding the same |
| 06/08/1994 | EP0600136A1 Intron/Exon structure of the human and mouse Beta 3 Adrenergic receptors genes |
| 06/08/1994 | EP0600036A1 Method for generating and screening useful peptides |
| 06/08/1994 | EP0600018A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 06/08/1994 | EP0600000A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 06/08/1994 | EP0599990A1 Hla typing |
| 06/08/1994 | EP0599978A1 Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula |
| 06/08/1994 | EP0599971A1 Yeast promoter and use thereof |
| 06/08/1994 | EP0599913A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 06/08/1994 | EP0553287A4 Cytokine-induced marker for inflammatory response |
| 06/08/1994 | EP0553186A4 Method for producing t h?-independent cytotoxic t lymphocytes |
| 06/08/1994 | EP0531300B1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 06/08/1994 | EP0225887B1 A method and a hybrid promoter for controlling exogenous gene transcription |
| 06/08/1994 | CN1087681A Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 06/07/1994 | US5318901 Culturing TOLYPOCLADIUM in a nutrient containing 3-fluoro-alanine or 2-deutero-3-fluoro-alanine isotopes to get cyclic peptides immunosuppressants |
| 06/07/1994 | US5318900 Method for producing antiviral protein utilizing E. coli transformant, and gene and E. coli vector used in the method |
| 06/07/1994 | US5318899 Platelet aggregation inhibitors |
| 06/07/1994 | US5318897 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 06/01/1994 | EP0599822A2 Method of preparation and use for zona pellucida antigens for sterilization and contraception |
| 06/01/1994 | EP0599274A1 HER4, a human receptor tyrosine kinase of the epidermal growth factor receptor family |
| 06/01/1994 | EP0598998A2 Humanized antibodies reacting with the ganglioside GM2 |
| 06/01/1994 | EP0598840A1 Human calcium channel compositions and methods |
| 06/01/1994 | EP0598839A1 Purine-region dna binding protein |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0598806A1 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
| 06/01/1994 | EP0598768A1 Nucleotide sequences coding for ribosome inactivating proteins |
| 06/01/1994 | EP0479912B1 Inhibition of the n-end rule pathway in living cells |
| 06/01/1994 | EP0250501B2 A process for the preparation of a heat resistant non-bitter water-soluble peptide product, the product produced by the process, and nutrients, refreshments and dietetics comprising the product |
| 06/01/1994 | EP0200767B1 Sandwich immunoassay of antigens involved in ophthalmic disorders |
| 06/01/1994 | EP0172865B2 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
| 06/01/1994 | DE4228458A1 Multicistronische Expressionseinheiten und deren Verwendung Multicistronic expression units and their use |
| 06/01/1994 | CN1024809C Microorganism having low acetate forming capability and process for production of useful substrate using same |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |